SynthesisSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
The impact of hyperglycaemia and/or type 2 diabetes on women with breast cancer undergoing or post-cytotoxic chemotherapy: a systematic literature review.
Synthesis in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeHyperglycaemia and/or type 2 diabetes (T2D) can have a detrimental effect on women with breast cancer (BC) undergoing or post-cytotoxic chemotherapy. This systematic review aims to evaluate the short and long-term consequences of hyperglycaemia and/or T2D on treatment outcomes in women with breast cancer receiving cytotoxic chemotherapy.
methodsStudies published between 2018 and 2024 across four electronic databases were identified. The JBI critical appraisal tool was adopted to select high-quality studies.
resultsNine papers met the criteria for review. Thematic analysis identified two themes: 1) short-term consequences of hyperglycaemia and/or T2D, specifically its impact on healthcare utilisation, treatment toxicity, and treatment modification, and 2) long-term consequences of hyperglycaemia and/or T2D, such as effects on pathological response, prognosis, and mortality.
conclusionProactive identification and rigorous management of hyperglycaemia and/or T2D are essential to reducing complications and improving outcomes in women with BC receiving chemotherapy. Evidence demonstrates that poor glycaemic control clearly impairs treatment response. The current research gap and fragmented care pathways demand strengthened multidisciplinary collaboration and the delivery of personalised care. These measures are necessary to significantly improve the quality of living with and beyond a diagnosis of BC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.